Empowering indigenous communities through coproduced health research

Days af­ter a New Jer­sey fed­er­al judge tossed their law­suits against the In­fla­tion Re­duc­tion Act, John­son & John­son has fol­lowed Bris­tol My­ers Squibb and filed

Bris­tol My­ers Squib has made a $35 mil­lion in­vest­ment in­to the T cell-fo­cused biotech Im­mat­ics, pur­chas­ing over 2.4 mil­lion shares. The move will al­low for